Padmini Naidu, RPH
Pharmacist · Portland, OR
Padmini Naidu, RPH is a pharmacist with a practice address in Portland, Oregon, and NPI 1033423512, issued on Jul 27, 2010. Check the license (Oregon 9937, as entered in NPPES) with the Oregon board that licenses this profession; the Medicare figures below come from public CMS files.
- Name
- Padmini Naidu
- Credential
- RPH
- Primary taxonomy
- Pharmacist 183500000X
- License number
- 9937 OR
Self-reported in NPPES; status is on the state search - Practice location
- 5717 NE 138TH Ave, Portland, OR 97230
- Phone
- (503) 261-7951
- Enumerated
- Jul 27, 2010
- Entity
- Type 1 · individual
Also registered at 5717 NE 138TH Ave
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Zachary Anderson, PHARM.D.Ambulatory Care Pharmacist1497693022
- Michele Anhoury, RPHPharmacist1972050995
- Nicole Barclay, PHARM D.Pharmacist1588994115
- Amanda Bardeloza, PHARMDPharmacist1093292419
- Elizabeth Bentley, PHARMDPharmacist1124506753
- Ashley Blevins, PHARMD.Pharmacist1679839880
Verify Padmini Naidu in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWhich Oregon board licenses this profession
Search for license 9937Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS, AOA, NCCPA, AANPNot checked
68% fewer Medicare Part D claims than the average pharmacist in 2024
41 Medicare Part D claims, against an average of 127 among the 28,933 providers of this specialty who prescribed in Part D. Brand-name drugs were 0% of claims.
Most prescribed
- Warfarin Sodium41 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
1,019 pharmacist records list a Portland practice address
They are 1,019 of the 42,088 NPPES records with a Portland practice address, and 3,932 pharmacist records in Oregon.
All 1,019 in Portland → All 3,932 in Oregon → Every provider in Portland →
Other pharmacist records in Oregon
- Casey Aaby, PHARMDSpringfield, OR1114735909
- Zachary Aalberg, PHARMDMedford, OR1336757095
- Carly Aamoth, PHARM.DPortland, OR1659749380
- Linda Aare-Narits, RPHWood Village, OR1811235260
- Tahlia Aarstad, PHARMDKlamath Falls, OR1972928117
- Abdulahi Ababulgu, PHARMDPortland, OR1548942188
- Alyaa AbbasWoodburn, OR1477417293
- Abbas Abbaspour, PHARMACISTHillsboro, OR1558621474
- Diana AbdeljawadPortland, OR1578369229
- Gerissa AbdonBeaverton, OR1487364014
Common questions
What is Padmini Naidu, RPH's NPI number?
Padmini Naidu, RPH's National Provider Identifier (NPI) is 1033423512, issued on Jul 27, 2010. An NPI identifies a provider in billing; it is not a license.
Where is Padmini Naidu, RPH located?
The NPPES record lists a practice address at 5717 NE 138TH Ave, Portland, OR, 97230. Phone: (503) 261-7951. Providers update this record themselves, so call before visiting.
How can I verify Padmini Naidu, RPH's license?
NPPES lists Oregon license number 9937, as entered by the provider. Search the Oregon board that licenses this profession; the NPPES record confirms identity only.
How much does Padmini Naidu, RPH prescribe under Medicare Part D?
In 2024, Padmini Naidu, RPH had 41 Medicare Part D claims; the average among pharmacist prescribers was 127. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), loaded Aug 27, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 27, 2026.